Results 71 to 80 of about 25,193 (261)

P2X7 receptor antagonism suppresses epileptiform‐like activity in an inflammation‐primed human iPSC‐derived neuron model of drug‐resistant epilepsy

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Neuroinflammation is increasingly recognised to contribute to drug‐resistant epilepsy. Activation of ATP‐gated P2X7 receptors has emerged as an important upstream mechanism, and increased P2X7 receptor expression is present in the seizure focus in rodent models and patients. Pharmacological antagonists of P2X7 receptors attenuate
Jaideep Kesavan   +6 more
wiley   +1 more source

In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation setting

open access: yesPharmacology Research & Perspectives
UGT2B10 is a phase II drug metabolizing enzyme with limited information on its role in the metabolism of drugs, especially in the pediatric hematopoietic stem cell transplantation setting.
Yahia Bennani   +7 more
doaj   +1 more source

Tics as a Presenting Symptom in Catatonia

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Lindsey M. Vogt   +3 more
wiley   +1 more source

Prognostic factors and impact of management strategies for status epilepticus: The STEPPER study in the Emilia‐Romagna region, Italy

open access: yesEpilepsia, Volume 66, Issue 3, Page 753-767, March 2025.
Abstract Objective The STEPPER (Status Epilepticus in Emilia‐Romagna) study aimed to investigate the clinical characteristics, prognostic factors, and treatment approaches of status epilepticus (SE) in adults of the Emilia‐Romagna region (ERR), Northern Italy.
Lidia Di Vito   +56 more
wiley   +1 more source

The phenomenology and treatment response in catatonia: A hospital based descriptive study

open access: yesIndian Journal of Psychological Medicine, 2017
Background: Literatures regarding clinical symptomatology and treatment response of catatonia are very few. Objective: To assess onset, clinical profile, diagnostic break up, treatment response and outcome in patients diagnosed as Catatonia, reported to ...
Sarada Prasanna Swain   +2 more
doaj   +1 more source

The gut microbiome associated with LGI1‐antibody encephalitis

open access: yesEpilepsia, EarlyView.
Abstract Objective Autoimmune encephalitis is a cause of brain inflammation characterized by auto‐antibodies, which target cell surface neuronal proteins and lead to neuronal dysfunction. The most common form is associated with auto‐antibodies to leucine‐rich glioma‐inactivated 1 (LGI1) protein, the presentation of which includes frequent focal ...
Edmund Gilbert   +12 more
wiley   +1 more source

Prescripción de lorazepam dentro de la caja Costarricense del seguro social

open access: yesJournal Health NPEPS, 2019
Objetivo: describir la prescripción de lorazepam dentro de la caja Costarricense del seguro social. Método: el estudio es descriptivo y retrospectivo, de enero de 2011 a diciembre de 2015. La investigación consistió en 339,484 prescripciones de lorazepam.
Consuelo María Cubero Alpízar   +2 more
doaj  

Respiratory dysfunction and fatal apnea during pilocarpine‐induced status epilepticus

open access: yesEpilepsia, EarlyView.
Abstract Objective Status epilepticus (SE) is second only to sudden unexpected death in epilepsy as a cause of seizure‐related mortality. The progression of respiratory dysfunction during experimental SE remains poorly characterized. We investigated how pilocarpine‐induced SE affects respiration in mice.
Chengsan Sun   +6 more
wiley   +1 more source

Quantitative Analysis of Lorazepam in Pharmaceutical Formulation Through FTIR Spectroscopy

open access: yesE-Journal of Chemistry, 2012
A Fourier transform infrared (FTIR) spectrophotometric method was development for the rapid, direct measurement of lorazepam in different pharmaceutical products.
Elaheh Konoz   +3 more
doaj   +1 more source

A case report of preferential effectiveness of clonazepam over lorazepam in the management of a case of alprazolam withdrawal

open access: yesJournal of Geriatric Mental Health, 2018
Benzodiazepines (BZDs) remain the mainstay in the management of withdrawal arising out of BZD use disorders. The choice of detoxifying agent is determined by the duration of action and also by the metabolic properties of the drug.
Vrinda Saxena, Robin Victor, Arghya Pal
doaj   +1 more source

Home - About - Disclaimer - Privacy